DASA-58

Research use only, not for human use.

DASA-58 is a specific and potent Pyruvate kinase M2 (PKM2) activator.

DASA-58 is a specific and potent Pyruvate kinase M2 (PKM2) activator.

DASA-58 (15 μM; 2 h) potentiates the antitumor effects of other metabolic stressors.?DASA-58 (15 μM; 24 h, 72 h) enhances pyruvate kinase activity in breast cancer cells without a clear effect on proliferation.?DASA-58 (30 μM, 60 μM; 0-72 h) enhances extracellular acidification and lactate levels in BCa cell lines and induce extracellular acidification levels in prostate cancer cell lines.DASA-58 (15 μM, 30 μM; 0-72 h) affects respiration levels in BCa cells without an indication of mitochondrial damage.DASA-58 (15 μM; 0-72 h) not rescues TXNIP levels in any combintion and mitochondrial inhibitors enhance PKM2 effects on activating AMPK signaling (T172 phosphorylation of AMPK) .DASA-58 (15 μM; 0-72 h) leads to depletion in TXNIP levels independent of AMPK and ER signaling, and not through enhanced proteasomal degradation but rather depleted upstream glycolytic intermediates. Cell Viability Assay Cell Line:Five breast cancer cell lines (BCa cells) (MDA MB 231, MDA MB 468, HCC 1443, T47-D, MCF7, LnCap, PC3, and DU145)Concentration:15 μM Incubation Time:2 h Result:Could be exploited by other metabolic stressors.Western Blot Analysis Cell Line:BCa cells Concentration:15 μM Incubation Time:24 h, 72 h Result:Showed comparable PKM2 protein levels in five breast cancer cell lines, except HCC1443 cells and MDA MB 468 that showed the highest and lowest PKM2 protein levels, respectively.

——

——

Angiogenesis

CDK

PKM2

Cancer

——

1203494-49-8

453.53

C19H23N3O6S2

>98% (HPLC)

DMSO : ≥ 35 mg/mL 77.17 mM

c1(cc(ccc1)S(=O)(=O)N1CCN(CCC1)S(=O)(=O)c1cc2OCCOc2cc1)N

——

(-20℃)

With Ice Pack

≥ 2 years